By Mallory Olson A group of University of Kentucky professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS). “Rapid repurposing of drugs for COVID-19,” is authored by Kip…
Stroke survivor, stroke support group receive awards
By Beth Bowling and Hillary Smith The Hazard and Surrounding Area Stroke Survivor and Caregiver Support Group through the University of Kentucky Center of Excellence in Rural Health, along with one of the group’s founding members, Mark Kincaid, a stroke survivor from Letcher County, were honored with Stroke Hero Awards from the American Stroke Association,…
XLerateHealth, Southeast XLerator Network announce National Institutes of Health funding
XLerateHealth (XLH), its affiliate, the Southeast XLerator Network (XLN) and XLN Academic Lead, the University of Kentucky, announced that the National Institutes of Health (NIH) has approved XLN’s External Advisory Committee’s (EAC) recommendation to fund the continued development of seven biomedical innovations that represent various areas of technology, from medical devices to diagnostics and therapeutics. The funding…
COVID-19 survivors sought for plasma donations
UK HealthCare physicians may start administering convalescent plasma from recovered COVID-19 patients to those with severe COVID-19 infections. The FDA recently released guidelines allowing the investigative therapy, which may show promise in helping COVID-19 patients recover faster by offering passive immunity. UK HealthCare and Baptist Health have partnered with the Kentucky Blood Center to collect donations from COVID-19 survivors…
UK working to reduce opioid-related deaths in Kentucky
By Sally McMahon The University of Kentucky’s (UK) Center on Drug and Alcohol Research (known as CDAR) conducts research on numerous aspects of substance abuse and related behavior, including intimate violence, criminal justice settings and characteristics of rural substance use. CDAR has a history of providing training on evidence-based treatment, intervention and prevention approaches, as…
A quest for new therapeutics
By Sally McMahon Linda Dwoskin, PhD, professor and associate dean of research at the University of Kentucky College of Pharmacy, is leading research on methamphetamine use disorder and working to develop a medication to treat the disorder. We talked to Dwoskin recently about what it takes to develop treatment options and how she works with…